PACB 1.47 ▲ 5.00% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pacific Biosciences of Ca...

    NASDAQ: PACB · Real-Time Price · USD
    1.47
    0.07 (5.00%)
    At close: Oct 08, 2025, 10:20 AM
    5.00%
    Bid 1.03
    Market Cap 441.54M
    Revenue (ttm) 156.11M
    Net Income (ttm) -526.36M
    EPS (ttm) -2.23
    PE Ratio (ttm) -0.66
    Forward PE -2.87
    Analyst Hold
    Dividends n/a
    Ask 1.83
    Volume 1,578,678
    Avg. Volume (20D) 6,858,010
    Open 1.44
    Previous Close 1.40
    Day's Range 1.41 - 1.47
    52-Week Range 0.85 - 2.72
    Beta 2.10
    Ex-Dividend Date n/a

    About PACB

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PACB
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for PACB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Pacific Biosciences of California Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +7.14%
    Pacific Biosciences shares are trading higher afte... Unlock content with Pro Subscription
    2 months ago
    -8.7%
    PACB stock has given up its prior gain. Pacific Biosciences shares were trading higher after the company reported better-than-expected Q2 financial results.
    news image

    1 day ago · zacks.com

    Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today

    In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.52, marking a +2.01% move from the previous day.

    news image

    1 week ago · zacks.com

    PacBio Enters Carrier Screening Market With PureTarget Expansion

    PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.

    news image

    2 weeks ago · zacks.com

    Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts

    In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.29, indicating a +1.57% shift from the previous trading day.

    news image

    3 weeks ago · zacks.com

    Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today

    In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.17, denoting a -7.14% move from the preceding trading day.

    news image

    4 weeks ago · seekingalpha.com

    Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

    Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants Christian Henry - President, CEO & D...

    news image

    1 month ago · zacks.com

    PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq

    PacBio collaborates with EpiCypher to integrate Fiber-Seq and HiFi sequencing, advancing single-molecule epigenomics with new chromatin mapping tools.

    news image

    2 months ago · seekingalpha.com

    Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript

    Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.

    news image

    2 months ago · zacks.com

    PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises

    PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.

    news image

    2 months ago · fool.com

    PACB Sales Up 11%

    PACB Sales Up 11%

    news image

    2 months ago · zacks.com

    Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

    The headline numbers for Pacific Biosciences (PACB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre...

    Add to Watchlist